Pharmafile Logo
Pharmafocus logo
Advanced Search
medications-money-cure-tablets

Indian regulators approve first drug for patients with NASH

March 6, 2020
Medical Communications FDA Approval, India, Indian Pharma, drug approval

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

News
shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020
Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …

News
transportation_isolation_system_1

UK cases of coronavirus hit 90 as health officials move into next phase of their response

March 5, 2020
Business Services Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

The coronavirus has continued to spread across the UK as health officials announce they have moved into the second stage …

News

China approves Roche’s Actemra to fight severe complications stemming from coronavirus

March 5, 2020
Sales and Marketing Actemra, China, Roche, coronavirus, pharma

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …

News
4972850923_170b36c774

Researchers have tested CRISPR gene editing inside a person’s body for the first time

March 5, 2020
Business Services Editas, crispr, gene editing

Allergan and Editas Medicine have treated their first patient in a clinical trial with CRISPR gene editing. This therapy is …

News
8265405611_337b629f7f_b

US prescription drug net costs rose three times faster than inflation from 2007 to 2018

March 5, 2020
Business Services Big Pharma, Trump drug prices, US Drug prices, drug prices, us drugs

The nest cost of prescription drugs rose over three times faster than the rate of inflation over the course of …

News
takeda_logo_506_small

Positive CHMP approval for Takeda’s Alunbrig in ALK+ advanced non-small lung cancer

March 4, 2020
Research and Development CHMP, EMA, Takeda, lung cancer, pharma

Takeda’s Alunbrig (brigatinib) has been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …

News
chart-trading-courses-forex-preview

Big Pharma more profitable than most public firms

March 4, 2020
Research and Development Big Pharma, US Pharma, drug prices, drug regulations, regulations

Large pharmaceutical companies make a much larger profit than most other public companies, according to a new study. The research …

News
diet-pills-medication-pharmacy-sick

India reducing API exports due to coronavirus threatening global supply chain

March 4, 2020
Research and Development APIs, Active Pharmaceuticals Ingredients, Big Pharma, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …

News
nice_new_london_office_internal_3_web

NICE recommends avatrombopag to treat thrombocytopenia in chronic liver disease

March 4, 2020
Research and Development Avatrombopag, NHS, NICE, UK, chronic liver disease

UK drug watchdog NICE has announced its final draft guidance recommending avatrombopag for routine use on the NHS in England …

News
48317770967_48ec28d656_b

Trump meets pharmaceutical executives to discuss COVID-19 vaccine

March 4, 2020
Research and Development COVID-19, Chinese Coronavirus, Trump, Wuhan Coronavirus, coronavirus

President Trump has met with several representatives of the top pharmaceutical companies to discuss progress being made on a coronavirus …

News
pd36-1-ksc-20170808-ph_csh01_0023

MSD’s Phase 3 study of lymphoma treatment meets primary endpoints

March 3, 2020
Manufacturing and Production B-cell lymphoma, classical Hodgkin Lymphoma, lymphoma

MSD announced that its Phase 3 study of Keytruda (pembrolizumab) for the treatment of adults with relapsed or refractory classical …

News
gilead_hq_at_stockley_park_london_2

Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal

March 3, 2020
Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma

Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …

News
1024px-u

Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case

March 3, 2020
Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing

Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …

News

Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma

March 3, 2020
Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma

Sanofi’s monoclonal antibody and CD-38 inhibitor Sarclisa (isatuximab-irfc) has been awarded marketing authorisation from the FDA in the treatment of …

News
surgery-in-hospital-clinic-and-doctors-206-small

99% of Doctors feel NHS is not ready to deal with coronavirus, new survey finds

March 3, 2020
Manufacturing and Production Boris, Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Most NHS doctors, that partcipated in a survey, feel the organization is not well prepared to deal with a major …

News
michael-jewell

Funding overview for the pharmaceutical industry and outlook for 2020

March 2, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma

This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …

Feature
gwpharma

GW Pharma takes back control of UK Sativex sales from Bayer

March 2, 2020
Sales and Marketing Bayer, GW Pharma, Sativex, UK

British firm GW Pharmaceuticals has revealed that it plans to reclaim the commercialisation rights to market its cannabis-based multiple sclerosis …

News
26629351446_42eeafa009_b_1

UK Health Secretary says no tactics will be “off the table” in dealing with coronavirus

March 2, 2020
Sales and Marketing Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

British Health Secretary Matt Hancock has said nothing will be “off the table” in tackling the coronavirus as cases in …

News
martin_shkreli_2016

FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim

March 2, 2020
Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma

The FDA has awarded approval to the first generic medicine for the treatment of toxoplasmosis, authorising Cerovene’s version of Daraprim …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026